Abstract| Volume 23, ISSUE 10, SUPPLEMENT , S35, October 2017

Reversible Renal Function following Implantable Ventricular Assist Device in a Patient with Dilated Cardiomyopathy Complicated by Autosomal Dominant Polycystic Kidney

      Systemic organ condition should be considered before implantation of left ventricular assist device (LVAD) as a bridge to cardiac transplantation. It is, nevertheless, difficult to evaluate the reversibility of organ function such as kidney and liver which are directly affected by hemodynamics. We experienced a 44-year old woman with autosomal dominant polycystic kidney disease who was also diagnosed with dilated cardiomyopathy. She also had moderately impaired renal function (serum creatinine level: 1.8 mg/dL). We calculated kidney prognosis before LVAD implantation, and estimated that there would be more than ten years for functional terminus of kidney using total kidney volume (433 mL/m). We further estimated the presence of prerenal factors affecting her kidney condition, which would be recovered after LVAD implantation. Indeed, her renal function was significantly improved after LVAD implantation (serum creatinine level: 1.0 mg/dL). In this presentation, we will demonstrate pre-/post-LVAD-implantation treatment strategy for a dilated cardiomyopathy patient concomitant with organic kidney disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Cardiac Failure
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect